News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KineMed, Inc. Receives Enabling Technology Award for Pathway Based Drug Discovery From Frost & Sullivan



11/13/2012 9:31:49 AM

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today that it has been awarded the prestigious Frost & Sullivan 2012 North American Enabling Technology Award for Pathway Based Drug Discovery. KineMed’s novel biomarkers facilitate development of evidence based medicines and diagnostics for complex diseases. The company uses proprietary mass spectroscopy methods that measure flux in proteins and metabolites in vivo.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES